Our rapidly expanding genetic knowledge points toward a near future in which the elements of the human body could be produced, manipulated, commodified, and exchanged. Contributors to this groundbreaking volume - academics and practitioners from the corporate sector, representing a diversity of backgrounds in business, social science, and philosophy internationally - discuss the challenges of genetic commerce, both as a topic of understanding and as a process requiring direction, certain to remain at the core of ethical debate for decades to come. Edited by renowned business ethicist Robert W. Kolb, all articles are new for this volume.